{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:13:54Z","timestamp":1790144034815,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.antiviral.2006.02.003","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T19:32:25Z","timestamp":1141241545000},"page":"132-139","source":"Crossref","is-referenced-by-count":7,"title":["The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus)"],"prefix":"10.1016","volume":"70","author":[{"given":"Jean Michel","family":"Heraud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Mortreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Merien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Contamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Mahieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Francois","family":"Pouliquen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Wattel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Gessain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"de Th\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirdad","family":"Kazanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2006.02.003_bib1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.leu.2403176","article-title":"Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia\/lymphoma","volume":"18","author":"Arnulf","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.antiviral.2006.02.003_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0952-7915(00)00107-2","article-title":"The immune response to HTLV-I","volume":"12","author":"Bangham","year":"2000","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2006.02.003_bib3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood.V93.1.278","article-title":"Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells","volume":"93","author":"Bazarbachi","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2006.02.003_bib4","first-page":"2399","article-title":"Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR\/c-myc and Ig\/tax genes","volume":"7","author":"Benvenisty","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2006.02.003_bib5","first-page":"2419","article-title":"Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP\/HAM","volume":"12","author":"Cavrois","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2006.02.003_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.onc.1201906","article-title":"Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis\/HTLV-1 associated myelopathy","volume":"17","author":"Cavrois","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2006.02.003_bib7","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1182\/blood.V88.12.4646.bloodjournal88124646","article-title":"Adult T-cell leukemia\/lymphoma on a background of clonally expanding human T-cell leukemia virus type-1-positive cells","volume":"88","author":"Cavrois","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2006.02.003_bib8","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/ijc.2910600612","article-title":"Molecular detection of pre-ATL state among healthy HTLV-1 carriers in an endemic area of Japan","volume":"60","author":"Chen","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2006.02.003_bib9","doi-asserted-by":"crossref","first-page":"7514","DOI":"10.1038\/sj.onc.1208896","article-title":"Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1","volume":"24","author":"Debacq","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2006.02.003_bib10","first-page":"2849","article-title":"Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation","volume":"96","author":"El-Sabban","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2006.02.003_bib11","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/JVI.63.7.3185-3189.1989","article-title":"Thymic atrophy characteristic in transgenic mice that harbor pX genes of human T-cell leukemia virus type I","volume":"63","author":"Furuta","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.02.003_bib12","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1128\/MCB.9.11.4731","article-title":"Trans activation of granulocyte-macrophage colony-stimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type 1 tax gene","volume":"9","author":"Green","year":"1989","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.antiviral.2006.02.003_bib13","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood.V95.4.1386.004k22_1386_1392","article-title":"Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes","volume":"95","author":"Hanon","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2006.02.003_bib14","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","article-title":"Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa","volume":"332","author":"Hermine","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2006.02.003_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/sj.thj.6200374","article-title":"Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed\/refractory adult T-cell leukemia\/lymphoma","volume":"5","author":"Hermine","year":"2004","journal-title":"Hematol. J."},{"key":"10.1016\/j.antiviral.2006.02.003_bib16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/ijc.2910290606","article-title":"Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study","volume":"29","author":"Hinuma","year":"1982","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2006.02.003_bib17","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ijc.2910580324","article-title":"Infection of rats with human T-cell leukemia virus type-I: susceptibility of inbred strains, antibody response and provirus location","volume":"58","author":"Ibrahim","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2006.02.003_bib18","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1089\/08892220050193245","article-title":"HTLV type 1 infection in squirrel monkeys (Saimiri sciureus): a promising animal model for HTLV type 1 human infection","volume":"16","author":"Kazanji","year":"2000","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.antiviral.2006.02.003_bib19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<300::AID-IJC27>3.0.CO;2-J","article-title":"Expression and immunogenicity in rats of recombinant adenovirus 5 DNA plasmids and vaccinia virus containing the HTLV-I env gene","volume":"71","author":"Kazanji","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2006.02.003_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1097-0215(19970926)73:1<131::AID-IJC20>3.0.CO;2-I","article-title":"Role of the genetic background of rats in infection by HTLV-I and HTLV-II and in the development of associated diseases","volume":"73","author":"Kazanji","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2006.02.003_bib21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/viro.1997.8528","article-title":"HTLV-I infection in squirrel monkey (Sa\u00efmiri sciureus) using autologous, homologous or heterologous HTLV-I-transformed cell lines","volume":"231","author":"Kazanji","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2006.02.003_bib22","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1128\/JVI.74.10.4860-4867.2000","article-title":"Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responses","volume":"74","author":"Kazanji","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.02.003_bib23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1046\/j.1365-2141.1998.00743.x","article-title":"Oligoclonal proliferation of human T-cell leukaemia virus type 1 bearing T cells in adult T-cell leukaemia\/lymphoma without deletion of the 3\u2019 provirus integration sites","volume":"101","author":"Leclercq","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.antiviral.2006.02.003_bib24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1365-2141.1999.01389.x","article-title":"Semiquantitative analysis of residual disease in patients treated for adult T-cell leukaemia\/lymphoma (ATLL)","volume":"105","author":"Leclercq","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.antiviral.2006.02.003_bib25","first-page":"233","article-title":"Regulation of NF-kappaB by the HTLV-1 Tax protein","volume":"7","author":"Li","year":"1999","journal-title":"Gene Exp."},{"key":"10.1016\/j.antiviral.2006.02.003_bib26","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1182\/blood.V98.13.3762","article-title":"Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage","volume":"98","author":"Mahieux","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2006.02.003_bib27","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1128\/JVI.75.2.1083-1089.2001","article-title":"Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus)","volume":"75","author":"Mortreux","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.02.003_bib28","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP","volume":"4","author":"Nagai","year":"1998","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.antiviral.2006.02.003_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ijc.2910400203","article-title":"Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis","volume":"40","author":"Nakada","year":"1987","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.antiviral.2006.02.003_bib30","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2002-09-2986","article-title":"Arsenic\/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells","volume":"101","author":"Nasr","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2006.02.003_bib31","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984\u201387)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.antiviral.2006.02.003_bib32","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJM199811053391901","article-title":"Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide","volume":"339","author":"Soignet","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2006.02.003_bib33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00042560-199909010-00012","article-title":"Prospective study of HTLV-I infection in an initially asymptomatic cohort","volume":"22","author":"Taylor","year":"1999","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.antiviral.2006.02.003_bib34","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V89.3.948","article-title":"Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease","volume":"89","author":"Tsukasaki","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2006.02.003_bib35","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood.V82.6.1701.1701","article-title":"The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia","volume":"82","author":"Waldmann","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2006.02.003_bib36","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/art.1780361117","article-title":"Inflammatory polyarthritis in mice transgenic for human T cell leukemia virus type I","volume":"36","author":"Yamamoto","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.antiviral.2006.02.003_bib37","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1073\/pnas.81.8.2534","article-title":"Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease","volume":"81","author":"Yoshida","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354206000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354206000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:08Z","timestamp":1586736008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354206000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0166354206000350"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2006.02.003","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}